Patent · US Active

Modified adenoviruses

US11591619B2 · kind B2 · utility

0Cited by

103References

41Claims

0Family size

Assignee

Gritstone Bio, Inc. · US

Inventors

Karin Jooss · Emeryville, US
Ciaran Daniel Scallan · San Francisco, US
Leonid Gitlin · Foster City, US

Key dates

Filing date	Nov 30, 2021
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Nov 30, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/203
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions include modified adenoviruses. Nucleotides, cells, and methods associated with the compositions, including their use as vaccines. Viral vectors using a TET promoter system and methods of producing viruses having the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.